standards > terminology artifact > DOI:10.25504/FAIRsharing.ddmatg


ready Ontology of Drug Neuropathy Adverse Events

Abbreviation:ODNAE


General Information
The Ontology of Drug Neuropathy Adverse Events (ODNAE) is an extension of OAE which serves as a knowledge base comprising drug components, chemical entities of active drug ingredients, drug mechanisms, and drug-inducing neuropathy AEs. ODNAE is a platform for building a drug-induced neuropathy knowledge base and for analyzing the underlying mechanisms of drug-induced neuropathy. The ODNAE-based methods used in this study can also be extended to the representation and study of other categories of adverse events.



How to cite this record FAIRsharing.org: ODNAE; Ontology of Drug Neuropathy Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.ddmatg; Last edited: Feb. 22, 2018, 2:02 p.m.; Last accessed: Sep 24 2018 4:46 p.m.


Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Feb. 20, 2018, 2:24 p.m. by The FAIRsharing Team.

Show edit history



Support

No support information provided.

Additional Information

External Links


Tools

    No tools defined


Schemas

No XSD schemas defined


Access / Retrieve Data

Conditions of Use

Applies to: Data use




Publications

Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events.

Guo A,Racz R,Hur J,Lin Y,Xiang Z,Zhao L,Rinder J,Jiang G,Zhu Q,He Y
J Biomed Semantics 2016

View Paper (PubMed) View Publication

ODNAE Ontology Display

View in BioPortal.


Disclaimer: This widget assumes the availability of the ontology resources in the NCBO BioPortal.


Related Standards

Reporting Guidelines

No guidelines defined

Models and Formats

No syntax standards defined

Identifier Schemas

No identifier schema standards defined


Implementing Databases (0)

No Related Databases


Implementing Policies

This record is not implemented by any policy.